Nano-X Imaging (NNOX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

NNOX Stock Forecast


Nano-X Imaging stock forecast is as follows: an average price target of $18.00 (represents a 184.81% upside from NNOX’s last price of $6.32) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

NNOX Price Target


The average price target for Nano-X Imaging (NNOX) is $18.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $18.00 to $18.00. This represents a potential 184.81% upside from NNOX's last price of $6.32.

NNOX Analyst Ratings


Buy

According to 2 Wall Street analysts, Nano-X Imaging's rating consensus is 'Buy'. The analyst rating breakdown for NNOX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Nano-X Imaging Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 02, 2024Ross OsbornCantor Fitzgerald$18.00$10.3374.25%184.81%
Row per page
Go to

The latest Nano-X Imaging stock forecast, released on Apr 02, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $18.00, which represents a 74.25% increase from the stock price at the time of the forecast ($10.33), and a 184.81% increase from NNOX last price ($6.32).

Nano-X Imaging Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$18.00
Last Closing Price$6.32$6.32$6.32
Upside/Downside-100.00%-100.00%184.81%

In the current month, the average price target of Nano-X Imaging stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nano-X Imaging's last price of $6.32. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2024Cantor FitzgeraldOverweightOverweightHold
Jan 19, 2024Cantor FitzgeraldOverweightOverweightHold
Sep 08, 2023Alliance Global Partners-BuyInitialise
Row per page
Go to

Nano-X Imaging's last stock rating was published by Cantor Fitzgerald on Apr 02, 2024. The company gave NNOX a "Overweight" rating, the same as its previous rate.

Nano-X Imaging Financial Forecast


Nano-X Imaging Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
Revenue---------------$2.45M$2.13M$2.44M$2.20M$1.81M$1.30M
Avg Forecast$41.48M$28.34M$20.20M$14.16M$9.35M$8.08M$7.22M$5.85M$4.69M$3.91M$3.93M$4.42M$2.82M$2.90M$3.15M$2.90M$2.65M$2.81M$2.35M$2.38M$750.00K
High Forecast$53.11M$36.28M$25.87M$18.13M$11.97M$10.35M$9.25M$7.49M$6.01M$5.00M$5.03M$5.65M$3.57M$3.71M$4.04M$3.71M$3.39M$3.60M$2.35M$2.50M$785.05K
Low Forecast$32.66M$22.32M$15.91M$11.15M$7.36M$6.37M$5.69M$4.61M$3.70M$3.08M$3.10M$3.48M$2.10M$2.28M$2.48M$2.28M$2.08M$2.22M$2.35M$2.27M$714.95K
# Analysts111111111311311111--2
Surprise %---------------0.85%0.81%0.87%0.94%0.76%1.74%

Nano-X Imaging's average Quarter revenue forecast for Jun 23 based on 1 analysts is $3.15M, with a low forecast of $2.48M, and a high forecast of $4.04M. NNOX's average Quarter revenue forecast represents a 28.93% increase compared to the company's last Quarter revenue of $2.45M (Mar 23).

Nano-X Imaging EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111311311111--2
EBITDA---------------$-18.31M$12.10M$-15.05M$-15.92M$-19.08M$-22.04M
Avg Forecast$-8.30M$-5.67M$-4.04M$-2.83M$-1.87M$-1.62M$-1.44M$-1.17M$-938.38K$-781.62K$-786.13K$-883.00K$-564.67K$-580.00K$-631.00K$-579.00K$-529.00K$-563.00K$-469.00K$-477.00K$-150.00K
High Forecast$-6.53M$-4.46M$-3.18M$-2.23M$-1.47M$-1.27M$-1.14M$-921.29K$-739.01K$-615.55K$-619.10K$-695.39K$-420.50K$-456.77K$-496.93K$-455.98K$-416.61K$-443.38K$-469.00K$-454.71K$-142.99K
Low Forecast$-10.62M$-7.26M$-5.17M$-3.63M$-2.39M$-2.07M$-1.85M$-1.50M$-1.20M$-1.00M$-1.01M$-1.13M$-714.84K$-742.66K$-807.97K$-741.38K$-677.36K$-720.89K$-469.00K$-499.29K$-157.01K
Surprise %---------------31.63%-22.88%26.73%33.94%40.01%146.90%

1 analysts predict NNOX's average Quarter EBITDA for Mar 23 to be $-579.00K, with a high of $-455.98K and a low of $-741.38K. This is -104.78% lower than Nano-X Imaging's previous annual EBITDA (Dec 22) of $12.10M.

Nano-X Imaging Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111311311111--2
Net Income---------------$-11.76M$-44.84M$-19.13M$-19.61M$-21.67M$-20.18M
Avg Forecast$3.76M$-916.48K$-3.89M$-6.28M$-8.24M$-8.82M$-9.29M$-9.92M$-12.45M$-10.56M$-12.53M$-15.08M$-17.59M$-17.40M$-15.37M$-19.72M$-24.94M$-24.36M$-14.67M$-14.73M$-19.06M
High Forecast$5.14M$-663.34K$-2.81M$-4.55M$-5.97M$-6.39M$-6.72M$-7.18M$-9.01M$-9.11M$-9.07M$-10.92M$-14.08M$-12.60M$-11.13M$-14.27M$-18.05M$-17.63M$-14.67M$-13.83M$-17.90M
Low Forecast$2.72M$-1.25M$-5.30M$-8.57M$-11.25M$-12.04M$-12.67M$-13.53M$-16.99M$-12.02M$-17.09M$-20.58M$-22.29M$-23.75M$-20.98M$-26.91M$-34.04M$-33.24M$-14.67M$-15.62M$-20.22M
Surprise %---------------0.60%1.80%0.79%1.34%1.47%1.06%

Nano-X Imaging's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NNOX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Nano-X Imaging SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111311311111--2
SG&A---------------$8.96M$9.68M$11.33M$12.23M$12.39M$12.86M
Avg Forecast$349.75M$238.95M$170.34M$119.42M$78.83M$68.16M$60.89M$49.32M$39.56M$32.95M$33.14M$37.23M$23.81M$24.45M$26.60M$24.41M$22.30M$23.74M$19.77M$20.11M$6.32M
High Forecast$447.84M$305.96M$218.11M$152.91M$100.93M$87.28M$77.97M$63.16M$50.66M$42.20M$42.44M$47.67M$30.14M$31.31M$34.07M$31.26M$28.56M$30.39M$19.77M$21.05M$6.62M
Low Forecast$275.44M$188.18M$134.15M$94.05M$62.08M$53.68M$47.95M$38.84M$31.16M$25.95M$26.10M$29.32M$17.73M$19.26M$20.95M$19.23M$17.57M$18.69M$19.77M$19.17M$6.03M
Surprise %---------------0.37%0.43%0.48%0.62%0.62%2.03%

Nano-X Imaging's average Quarter SG&A projection for Jun 23 is $26.60M, based on 1 Wall Street analysts, with a range of $20.95M to $34.07M. The forecast indicates a 196.89% rise compared to NNOX last annual SG&A of $8.96M (Mar 23).

Nano-X Imaging EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111311311111--2
EPS---------------$-0.21$-0.86$-0.37$-0.38$-0.42$-0.42
Avg Forecast$0.06$-0.02$-0.07$-0.11$-0.14$-0.15$-0.16$-0.17$-0.21$-0.18$-0.22$-0.26$-0.30$-0.30$-0.27$-0.34$-0.43$-0.42$-0.25$-0.26$-0.33
High Forecast$0.09$-0.01$-0.05$-0.08$-0.10$-0.11$-0.12$-0.12$-0.16$-0.16$-0.16$-0.19$-0.24$-0.22$-0.19$-0.25$-0.31$-0.30$-0.25$-0.24$-0.31
Low Forecast$0.05$-0.02$-0.09$-0.15$-0.19$-0.21$-0.22$-0.23$-0.29$-0.21$-0.29$-0.35$-0.38$-0.41$-0.36$-0.46$-0.59$-0.57$-0.25$-0.27$-0.35
Surprise %---------------0.62%2.00%0.88%1.50%1.65%1.27%

According to undefined Wall Street analysts, Nano-X Imaging's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NNOX previous annual EPS of $NaN (undefined).

Nano-X Imaging Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
NVCRNovoCure$18.57$67.92265.75%Hold
NNOXNano-X Imaging$6.32$18.00184.81%Buy
IARTIntegra LifeSciences$17.47$43.25147.57%Sell
ALGNAlign$243.73$554.38127.46%Buy
PACBPacific Biosciences of California$1.81$3.0065.75%Buy
HYPRHyperfine$1.04$1.6053.85%Buy
EWEdwards Lifesciences$68.52$97.0941.70%Buy
MDTMedtronic$90.00$106.7718.63%Hold
DXCMDexCom$69.51$81.8617.77%Buy
ABTAbbott Laboratories$116.40$129.5011.25%Buy
SYKStryker$370.25$305.00-17.62%Buy
SWAVShockWave Medical$334.75$258.17-22.88%Hold

NNOX Forecast FAQ


Yes, according to 2 Wall Street analysts, Nano-X Imaging (NNOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of NNOX's total ratings.

Nano-X Imaging (NNOX) average price target is $18 with a range of $18 to $18, implying a 184.81% from its last price of $6.32. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for NNOX stock, the company can go up by 184.81% (from the last price of $6.32 to the average price target of $18), up by 184.81% based on the highest stock price target, and up by 184.81% based on the lowest stock price target.

NNOX's average twelve months analyst stock price target of $18 supports the claim that Nano-X Imaging can reach $9 in the near future.

Nano-X Imaging's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $30.5M (high $39.06M, low $24.02M), average EBITDA is $-6.1M (high $-4.804M, low $-7.811M), average net income is $-36.271M (high $-26.252M, low $-49.494M), average SG&A $257.2M (high $329.34M, low $202.56M), and average EPS is $-0.625 (high $-0.453, low $-0.853). NNOX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $104.18M (high $133.39M, low $82.04M), average EBITDA is $-20.835M (high $-16.408M, low $-26.678M), average net income is $-7.32M (high $-2.886M, low $-12.402M), average SG&A $878.46M (high $1.12B, low $691.82M), and average EPS is $-0.126 (high $-0.0498, low $-0.214).

Based on Nano-X Imaging's last annual report (Dec 2022), the company's revenue was $8.58M, which missed the average analysts forecast of $10.19M by -15.82%. Apple's EBITDA was $-37.194M, beating the average prediction of $-2.038M by 1725.03%. The company's net income was $-105M, beating the average estimation of $-78.701M by 33.73%. Apple's SG&A was $45.63M, missing the average forecast of $85.93M by -46.90%. Lastly, the company's EPS was $-2.01, beating the average prediction of $-1.358 by 47.98%. In terms of the last quarterly report (Mar 2023), Nano-X Imaging's revenue was $2.45M, missing the average analysts' forecast of $2.9M by -15.47%. The company's EBITDA was $-18.312M, beating the average prediction of $-579K by 3062.70%. Nano-X Imaging's net income was $-11.761M, missing the average estimation of $-19.722M by -40.37%. The company's SG&A was $8.96M, missing the average forecast of $24.41M by -63.29%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-0.34 by -38.24%